Sex differences in the decline of neutralizing antibodies to SARS-CoV-2

Ludivine Grzelak; Aurélie Velay; Yoann Madec; Floriane Gallais; Isabelle Staropoli; Catherine Schmidt-Mutter; Marie-Josée Wendling; Nicolas Meyer; Cyril Planchais; David Rey; Hugo Mouquet; Ludovic Glady; Yves Hansmann; Timothée Bruel; Jérôme De Sèze; Arnaud Fontanet; Maria Gonzalez; Olivier Schwartz; Samira Fafi-Kremer.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20230466

Documentos relacionados

  1. Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
  2. Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019.
  3. SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.
  4. Factors influencing the immune response over 15 months after SARS-CoV-2 infection: A longitudinal population-wide study in the Faroe Islands.
  5. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.
  6. Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies.
  7. Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection.
  8. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
  9. SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period.
  10. Persistence of humoral response upon SARS-CoV-2 infection.